Blog

  • Medical Societies Renew Push for Prior Authorization Legislation

    December 11, 2025

    ACIP voted to end universal birth-dose hepatitis B vaccination, recommending the first dose at two months for infants of hepatitis B–negative mothers. Only infants of positive or unknown-status mothers get the birth dose. ASGE joined AASLD opposing this.

  • ACIP Votes Against Universal Birth-Dose of Hep B Vaccine

    December 11, 2025

    ACIP voted to end universal birth-dose hepatitis B vaccination, recommending the first dose at two months for infants of hepatitis B–negative mothers. Only infants of positive or unknown-status mothers would get the birth dose.

  • ASGE Answers Your Coding Questions

    December 9, 2025

    Many of our providers are asking if they can bill for a telephone or audio only visit to discuss test results with patients. This ended in May 2025, and the current guidelines do not appear to support reimbursement.

  • Case 33: APP Leadership – The Basics

    December 9, 2025

    This month’s case takes a different approach. Rather than focusing on a clinical scenario, we’re spotlighting leadership fundamentals for APPs and why they’re critical to the future of GI care.

  • The Future of Healthcare: Are Private Equity Partnerships Sustainable for Independent Practices?

    December 9, 2025

    Independent medical practices have long been the cornerstone of community-based care, offering patients personalized attention and continuity that large systems often struggle to provide.

  • Celebrating Collective Effort

    December 9, 2025

    Success reflects a collective effort as the course of 2025 reminded your GI colleagues. Read on for responses from ASGE committee members who share their lessons learned from the year.

  • ASGE Urges HCSC to Include Endoscopic Sleeve Gastroplasty (ESG) in Bariatric Surgery Policy

    December 3, 2025

    ASGE urges HCSC to update its Bariatric Surgery Policy to cover Endoscopic Sleeve Gastroplasty (ESG), now a Category I CPT® procedure effective Jan 1, 2026. ESG is FDA-authorized, guideline-endorsed, and proven safe, durable, and cost-effective.

  • ASGE Delegates Help Shape Policy at AMA House of Delegates Interim Meeting

    November 25, 2025

    ASGE physician leaders—Gary Richter, MD and Robin Mendelsohn, MD—represented gastroenterology at the AMA House of Delegates (HOD) Interim Meeting.

  • Physician Organizations Urge Elevance Health to Rescind Controversial Policy

    November 25, 2025

    A broad coalition of physician organizations, including ASGE, is urging Elevance Health to withdraw its new “Facility Administrative Policy: Use of a Nonparticipating Care Provider,” set to take effect in 11 states on January 1, 2026.

  • FDA Issues Draft Guidance for Demonstrating Biosimilarity

    November 14, 2025

    New draft industry guidance from the Food and Drug Administration (FDA) suggests the agency will change its approach to biosimilar review and no longer require comparative efficacy studies as part of an application for review.

  • White House Reaches Deal to Cut GLP-1 Prices

    November 14, 2025

    On November 6, President Trump announced that Eli Lilly and Novo Nordisk will offer their GLP-1 weight-loss drugs at a significant discount. As part of the deal, consumers will be able to buy the companies’ products at a significant discount on TrumpRx.

  • Telehealth Flexibilities Extended with Shutdown Deal

    November 14, 2025

    The deal to end the federal government shutdown passed by Congress and signed into law includes a number of health care extender provisions, including extension of the COVID-era telehealth flexibilities under Medicare.

  • ASGE Answers Your Coding Questions

    November 12, 2025

    Is there something (as a coder) that we can send on claims to avoid sequestration, reduction in federal payment?

  • Case 32: Acute Pancreatitis

    November 12, 2025

    A 46-year-old man with poorly controlled diabetes presents with a two day history of severe epigastric pain that radiates to his back with associated nausea and vomiting.

  • The Evolving Role of Clinical Research in Gastroenterology

    November 12, 2025

    Clinical research has long served as the bridge between scientific discovery and patient care. Today, its role in gastroenterology is expanding, shaping not only treatment options but also the patient–physician relationship.